Michael R. Dougherty, Director at Celator Pharmaceuticals Inc (CPXX), bought 20,000 shares at $2.15 ($43K) on 2014-11-18, disclosed to the SEC on 2014-11-20.
Open-market purchase of $43k CPXX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TRVN | BUY | 2014-12-10 | $28K | — | Filing → |
| VPHM | BUY | 2012-12-05 | $63K | — | Filing → |
| ADLR | BUY | 2010-12-23 | $35K | — | Filing → |